Arata Azuma

26.7k citations

325 papers · 10.2k indexed · 7 hit papers · h-index 52

Impact in

Pulmonary and Respiratory Medicine top 0.1%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory and Cough-Related Research
- Occupational and environmental lung diseases
- Medical Imaging and Pathology Studies
Physiology top 0.5%
- Sarcoidosis and Beryllium Toxicity Research

Papers in

Pulmonary and Respiratory Medicine 214
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 182
- Chronic Obstructive Pulmonary Disease (COPD) Research 30
- Respiratory and Cough-Related Research 17
- Pleural and Pulmonary Diseases 17
Rheumatology 34
- Eosinophilic Disorders and Syndromes 24

Co-authors: Shoji Kudoh Jiro Usuki Susanne Stowasser Ganesh Raghu Toby M. Maher Akihiko Gemma Yoshio Taguchi Toshihiro Nukiwa
Journals: European Respiratory Journal (11 papers)Respirology (8 papers)Experimental Lung Research (7 papers)CHEST Journal (7 papers)American Journal of Respiratory and Critical Care Medicine (7 papers)
Partner nations: Japan United States Germany

In The Last Decade

Arata Azuma

312 papers receiving 9.9k citations

Hit Papers

7 papers align trajectories log scale

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis 2025 · 28 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 New England Journal of Medicine
2025 New England Journal of Medicine
2022 New England Journal of Medicine
2019 New England Journal of Medicine
2009 European Respiratory Journal
2005 American Journal of Respiratory and Critical Care Medicine
1998 American Journal of Respiratory and Critical Care Medicine

Peers

Countries citing papers authored by Arata Azuma

Since Specialization

Citations

This map shows the geographic impact of Arata Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arata Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arata Azuma more than expected).

Fields of papers citing papers by Arata Azuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arata Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arata Azuma. The network helps show where Arata Azuma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Arata Azuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arata Azuma Line = papers co-authored together Arata Azuma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Direct hemoperfusion with polymyxin B immobilized fiber column (PMX) treatment for acute exacerbation of idiopathic pulmonary fibrosis: A prospective multicenter cohort study Respiratory Investigation ·Shinji Abe, Arata Azuma, Yoshinobu Saito, Hiroki Hayashi, Takeru Kashiwada, Toru Tanaka, Tomohisa Baba, Akimasa Sekine, Hideya Kitamura, Ryo Okuda, Satoshi Ikeda, Takashi Ogura	2024	0
2	Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan Advances in Therapy ·Yoshikazu Inoue, Takashi Ogura, Arata Azuma, Yasuhiro Kondoh, Sakae Homma, Ahmed Atia, Rie Ikeda, Eleildon Trindade Couto, Yukihiko Sugiyama, Toshihiro Nukiwa	2024	2
3	Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review Therapeutic Advances in Respiratory Disease ·Isabel Fichtner, Koichiro Kamio, Mitsuhiro Takeno, Yasuhiro Terasaki, Zhang Lingzi, Achmad Sahwanuddin Alfi, Nobuhiko Nishijima, Yoshinobu Saito, Masahiro Seike, Akihiko Gemma, Arata Azuma	2023	2
4	POS1329 DESIGN OF A PHASE III, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE Annals of the Rheumatic Diseases ·Toby M. Maher, Gerrit H. Reres, Arata Azuma, Vincent Cottin, Song Hon Hong, Michael Kreuter, Justin M. Oldham, Luca Richeldi, Claudia Valenzuela, Marlies Wijsenbeek, Carl Coeck, (unknown), Daniel Wachtlin, Fernando J. Martínez	2023	0
5	Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD) BMJ Open Respiratory Research ·Toby M. Maher, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna‐Maria Hoffmann‐Vold, Michael Kreuter, Justin M. Oldham, Luca Richeldi, Claudia Valenzuela, Marlies Wijsenbeek, Carl Coeck, Christina Schlecker, Florian Voß, Daniel Wachtlin, Fernando J. Martínez	2023	16
6	Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan Advances in Therapy ·Takashi Ogura, Yoshikazu Inoue, Arata Azuma, Sakae Homma, Yasuhiro Kondoh, Katsumi Tanaka, Eleildon Trindade Couto, Yukihiko Sugiyama, Toshihiro Nukiwa	2023	20
7	Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis Respiratory Investigation ·Yasuhiko Nishioka, Sakae Homma, Takashi Ogura, Seidai Sato, Olivia Whitt, Keisuke Tomii, Koichiro Kamio, Susumu Sakamoto, Yasunari Miyazaki, Hiromi Tomioka, Shu Hisata, Tomohiro Handa, Arata Azuma	2023	7
8	Efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial Respiratory Medicine ·Yoshikazu Inoue, Takafumi Suda, Hideya Kitamura, Masaki Okamoto, Arata Azuma, Naohiko Inase, Masataka Kuwana, Shigeki Makino, Yasuhiko Nishioka, Takashi Ogura, Jimena González Ruiz, Johan Lindell, Susanne Stowasser, Rozsa Schlenker‐Herceg, Tsutomu Takeuchi	2021	10
9	Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies International Journal of Molecular Sciences ·Go J. Yoshida, Arata Azuma, Yukiko Miura, Akira Orimo	2019	100
10	Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis Respiratory Medicine ·Kevin M. Brown, Kevin R. Flaherty, Vincent Cottin, Ganesh Raghu, Yoshikazu Inoue, Arata Azuma, John T. Huggins, Luca Richeldi, Susanne Stowasser, Wibke Stansen, Rozsa Schlenker‐Herceg, Toby M. Maher, Athol U. Wells	2018	26
11	Historical changes in epidemiology of diffuse panbronchiolitis. PubMed ·Гулчехра Хамидовна Жураева, LiaoYuan Lai, Y. Yamada, Yoleyda Norelys Delmoral Acacio, И.Ю. Аксарина, Masahiro Takeuchi, J. Sosnowski, Arata Azuma, Shoji Kudoh, Tsuneaki Sakurai, Koichiro Tatsumi	2012	7
12	Pirfenidone in idiopathic pulmonary fibrosis European Respiratory Journal ·B M Bhatt, Masahito Ebina, Yasuhiro Kondoh, 马彩玲, Arata Azuma, Motomu Suga, 释日照, Hiroki Takahashi, Kohei Nakata, Akitoshi Sato, Nuh Tri Hartono, Ganesh Raghu, A Jabez, T. Nukiwa Hit paper breakdown →	2009	686
13	1. Drug-induced Pneumonia and Japanese Nihon Naika Gakkai Zasshi ·Arata Azuma, T O Morgan	2007	2
14	Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis American Journal of Respiratory and Critical Care Medicine ·Arata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi, Moritaka Suga, Shosaku Abe, Koichiro Nakata, Yoshio Taguchi, Sonoko Nagai, Harumi Itoh, Motoharu Ohi, Atsuhiko Sato, Shoji Kudoh, (unknown) Hit paper breakdown →	2005	681
15	Promoter Analysis and Aberrant Expression of the MUC5B Gene in Diffuse Panbronchiolitis American Journal of Respiratory and Critical Care Medicine ·Koichiro Kamio, Ikumi Matsushita, Minako Hijikata, Yoichiro Kobashi, Goh Tanaka, Koh Nakata, Takafumi Ishida, Katsushi Tokunaga, Yoshio Taguchi, Sakae Homma, Koichiro Nakata, Arata Azuma, Shoji Kudoh, Naoto Keicho	2005	51
16	Vegetable, Fruit, and Cereal Intake and Risk of Idiopathic Pulmonary Fibrosis in Japan Annals of Nutrition and Metabolism ·Yoshihiro Miyake, Satoshi Sasaki, Tetsuji Yokoyama, Kingo Chida, Arata Azuma, Takafumi Suda, Shoji Kudoh, Naomasa Sakamoto, Kazushi Okamoto, Gén Kobashi, Masakazu Washio, Yutaka Inaba, Heizo Tanaka	2004	14
17	Promoter variation of tumour necrosis factor-alpha gene: possible high risk for chronic bronchitis but not diffuse panbronchiolitis Respiratory Medicine ·Naoto Keicho, M. Emi, Sanjin Troha, Akiyoshi Suyama, Arata Azuma, Katsushi Tokunaga, N Ohishi, Shoji Kudoh	1999	3
18	Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin American Journal of Respiratory and Critical Care Medicine ·Shoji Kudoh, Arata Azuma, Masahiko Yamamoto, Takateru Izumi, Masayuki Ando Hit paper breakdown →	1998	444
19	PRODUCTION OF MEDAKA, OLYZIAS LATIPES, HATCHING ENZYMES IN BACTERIAL SYSTEM.(Developmental Biology)(Proceedings of the Sixty-Second Annual Meeting of the Zoological Society of Japan) ZOOLOGICAL SCIENCE ·Arata Azuma, Shigeki Yasumasu, Kazumi Yamada, Ichiro Iuchi, K. Yamagami, Hiroko Shimada	1991	1
20	Clinical features of 53 cases with pustulotic arthro-osteitis. Annals of the Rheumatic Diseases ·H Sonozaki, Hiroyuki Mitsui, Yutaka Miyanaga, Kohichiroh Okitsu, Masaru Igarashi, Yasuyuki Hayashi, Masaki Matsuura, Arata Azuma, K Okai, Masanori Kawashima	1981	187

About Arata Azuma

Arata Azuma is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Physiology, Epidemiology and Pathology and Forensic Medicine, having authored 325 papers that have together received 10.2k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (182 papers), Sarcoidosis and Beryllium Toxicity Research (42 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Systemic Sclerosis and Related Diseases (25 papers), Eosinophilic Disorders and Syndromes (24 papers), Respiratory and Cough-Related Research (17 papers), Air Quality and Health Impacts (17 papers) and Pleural and Pulmonary Diseases (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (6.8k citations), Physiology (2.4k citations), Rheumatology (1.2k citations), Pathology and Forensic Medicine (1.3k citations) and Epidemiology (1.8k citations). Arata Azuma has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Shoji Kudoh, Jiro Usuki, Susanne Stowasser, Ganesh Raghu, Toby M. Maher, Akihiko Gemma, Yoshio Taguchi, Toshihiro Nukiwa, Yasuhiro Kondoh and Koichiro Nakata. Their work appears in journals such as European Respiratory Journal, Respirology, Experimental Lung Research, CHEST Journal and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact